Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Jul;26(1):89–91. doi: 10.1111/j.1365-2125.1988.tb03368.x

Effect of cicloprolol in intraocular pressure in healthy volunteers.

Q A Mekki 1, P Turner 1
PMCID: PMC1386504  PMID: 2904826

Abstract

Two oral doses of cicloprolol (50 mg and 100 mg), a beta 1-adrenoceptor partial agonist, were administered to nine healthy volunteers in a double-blind placebo-controlled study. Intraocular pressure (IOP) and exercise heart rate were reduced while the resting heart rate and blood pressure remained unchanged. The responses to the two different doses of cicloprolol were similar.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caldwell D. R., Salisbury C. R., Guzek J. P. Effects of topical betaxolol in ocular hypertensive patients. Arch Ophthalmol. 1984 Apr;102(4):539–540. doi: 10.1001/archopht.1984.01040030417014. [DOI] [PubMed] [Google Scholar]
  2. Elliot M. J., Cullen P. M., Phillips C. I. Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker. Br J Ophthalmol. 1975 Jun;59(6):296–300. doi: 10.1136/bjo.59.6.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fraunfelder F. T., Barker A. F. Respiratory effects of timolol. N Engl J Med. 1984 Nov 29;311(22):1441–1441. doi: 10.1056/nejm198411293112213. [DOI] [PubMed] [Google Scholar]
  4. Gorgone G., Spina F., Amantia L. Carteolol: preliminary study on ocular pressure-reducing action. Ophthalmologica. 1983;187(3):171–173. doi: 10.1159/000309320. [DOI] [PubMed] [Google Scholar]
  5. Grolman B. A new tonometer system. Am J Optom Arch Am Acad Optom. 1972 Aug;49(8):646–660. doi: 10.1097/00006324-197208000-00005. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES